Arphra/Issuer/TORNTPHARM.BO

TORNTPHARM.BO

Torrent Pharmaceuticals Limited

HealthcareDrug Manufacturers - Specialty & GenericININRCountry macro →

$4,285.05

Jun 02, 2026

AI Brief

Revenue · FY

$139.8B

Net income

$21.63B

FY 2026

EPS · diluted

$63.92

EBITDA

$34.62B

Explain this page

Arphra AIPlain-English read on Torrent Pharmaceuticals Limited’s valuation

AI Issuer Brief

Arphra AI

Loading cached brief…

Insider · 30d

Bought

0 txns

Sold

0 txns

Net flow

+$0

Full history →

Price

DB · prices_daily

1M 6M 1Y 5Y

Last

$4285.05

Change

+7.29%

Period high

$4571.90

Period low

$3973.05

Period start

$3994.002026-02-01

Through 2026-06-02

Peers

No peer list available for TORNTPHARM.BO.

Sector & industry today

Live

Sectors

Communication Services
+1.60%
Healthcare
+1.16%
Consumer Cyclical
+0.37%
Basic Materials
+0.31%
Energy
+0.16%
Real Estate
-0.08%
Utilities
-0.09%
Consumer Defensive
-0.13%
Industrials
-0.16%
Financial Services
-0.23%
Technology
-0.65%

Top industries (issuer's industry highlighted)

Drug Manufacturers - Specialty & Generic
+0.94%
Medical - Healthcare Information Services
-4.36%
Information Technology Services
-3.64%
Medical - Healthcare Plans
+3.05%
Communication Equipment
-2.50%
Oil & Gas Exploration & Production
+1.87%
Oil & Gas Energy
+1.49%
Discount Stores
-1.38%
Software - Application
-1.28%
Apparel - Manufacturers
-1.23%
Paper, Lumber & Forest Products
+1.09%
Medical - Instruments & Supplies
+1.04%

Fair value

Football field →

Weighted blend

$1,214.41

— vs spot

Recommendation

n/a

4 of 4 methods

Method spread

0bull0bear

±5% threshold

Total assets

$443.12B

Total debt

$150.25B

Cash & equiv

$11.65B

Operating CF

$26.32B

Free cash flow

$19.55B

Buybacks

Analyst view

Consensus target

—

No price-target data returned for this ticker.

Recent actions

0 ↑0 ↓0 hold

No recent grade actions.

News

DB · news_items

No recent news for TORNTPHARM.BO.

Recent quarters

All financials →

Period	Revenue	Net income	EPS

Recent insiders

All →

Insider	Action	Shares	Value	Date
No open-market insider activity in the recent window.

Income statement · annual

Open Financials →

Period	Revenue	Op income	Net income	EPS	Net margin
FY 2026	$139.8B	$34.62B	$21.63B	$63.92	+15.47%